When was AmacaThera founded?

AmacaThera was founded in 2015 and raised its 1st funding round 4 years after it was founded.

Where is AmacaThera located?

AmacaThera is headquartered in Toronto, Canada.

How many employees does AmacaThera have?

As of May 31, 2026, the latest employee count at AmacaThera is 18.

Is AmacaThera a funded company?

AmacaThera is a funded company, having raised a total of $14.2M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 11, 2019.

When was the latest funding round of AmacaThera?

AmacaThera's latest funding was a $***** Series A round on Feb 22, 2021, with participation from 9 investors.

Where does AmacaThera rank among its competitors?

AmacaThera ranks 4th amongst 20 active competitors, of which 5 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Regentis Biomaterials, which secured $6.5M in Jun, 2026.

Who are the top competitors of AmacaThera?

AmacaThera's top competitors include Regentis Biomaterials, GelMEDIX and Augmenix. Among them, Regentis Biomaterials secured the most recent funding round in June, 2026.

AmacaThera - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of an injectable hydrogel platform for a wide range of medical applications. It can be used for the therapeutic delivery of pharmacological agents for multiple disease areas. The company has also developed a combination product for post-operative pain.

Website: amacathera.ca
Phone Number: +1 **********

Key Metrics

Founded Year

2015

Location

Toronto, Canada

Stage

Series A

Total Funding

$14.2M in 3 rounds

Latest Funding Round

Series A, Feb 22, 2021, $*****

Investors

Sprout BioVentures & 15 more

Ranked

4^th among 20 active competitors

Employee Count

18 as on May 31, 2026

Similar Companies

Regentis Biomaterials & 21 more

View AmacaThera's full profile

AmacaThera has raised a total funding of $14.2M over 3 rounds. Its first funding round was on Jan 11, 2019. Its latest funding round was a Series A round on Feb 22, 2021 for $*****. 9 investors participated in its latest round. AmacaThera has 16 institutional investors.

Here is the list of recent funding rounds of AmacaThera:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 22, 2021	9715607	Series A	4544387	8481419	3471796	9697512
Oct 03, 2019	5121024	Seed	9946590	1906160	6671203	GSVP & 1 more
Jan 11, 2019	6665820	Seed	6653912	7216004	Sprout BioVentures & 1 more	GSVP

Access funding benchmarks and valuations. Sign up today!

View details of AmacaThera's funding rounds and investors

The founders of AmacaThera are Molly Shoichet and Mike Cooke.

Here are the details of AmacaThera's key team members:

Molly Shoichet: Co-Founder & CSO of AmacaThera. They serve on the board of 1 company.
Contact Info: 1 email address
Mike Cooke: Co-Founder & CEO of AmacaThera.
Contact Info: 1 email address

AmacaThera's Board of Directors

AmacaThera's board has 6 active members. Lu Han, Molly Shoichet, Eyal Ron, Michelle Scarborough, Paul Austin and Michael Cooke are independent board members.

Here is the list of AmacaThera's board of directors:

Name	Type	Representing	Status	Duration
Lu Han	Independent board member	-	Current	4y 8m
qdtjleb	Independent board member	-	Current	9y 8m
efjrpt{	Independent board member	-	Current	7y 7m
hyyvpfb	Independent board member	-	Current	2y 5m
fivktyi	Independent board member	-	Current	8y 2m
pskpnuy	Independent board member	-	Current	9y 1m

View details of AmacaThera's Founder profiles and Board Members

AmacaThera's employee count trend

AmacaThera has 18 employees as of May 26. Here is AmacaThera's employee count trend over the years:

Uncover AmacaThera's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AmacaThera include Regentis Biomaterials, GelMEDIX and Augmenix. Here is the list of Top 10 competitors of AmacaThera, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Regentis Biomaterials 2004, Or Akiva (Israel), Public	Biodegradable hydrogels for tissue regeneration.	$25M	DSM, Haisco Pharmaceutical Group & 9 others	58/100
2nd	GelMEDIX 2019, Newton (United States), Seed	Developer of a hydrogel drug delivery technology for ophthalmic treatment	$21M	Safar Partners, TiE Boston & 3 others	53/100
3rd	Augmenix 2008, Waltham (United States), Acquired	Provider of a hydrogel spacer for prostate cancer radiation therapy	$46.6M	Versant Ventures, Pinnacle Ventures & 5 others	52/100
4th	AmacaThera 2015, Toronto (Canada), Series A	Developer of an injectable hydrogel platform for a wide range of medical applications	$14.2M	Graphite Ventures, MBX Capital & 14 others	47/100
5th	OrthoTrophix 2011, Oakland (United States), Unfunded	Biopharmaceutical company developing therapies for hard tissue diseases like osteoarthritis	-	-	45/100
6th	LifeSprout 2015, Baltimore (United States), Series A	Developing revolutionary products for aesthetic and regenerative medicine	$44.7M	TEDCO, Kairos Ventures & 11 others	43/100
7th	Hy2Care 2014, Enschede (Netherlands), Series B	Developer of a hydrogel implant for cartilage defect repair	$15.5M	Brightlands Venture Partners, Startupbootcamp ... & 4 others	41/100
8th	BioCure 1999, Atlanta (United States), Funding Raised	Hydrogel medical device R&D and manufacturing, biocompatible materials expertise	-	-	40/100
9th	Amacathera 2017, Toronto (Canada), Funding Raised	Developer of injectable hydrogel platforms for localized drug delivery	-	Graphite Ventures	38/100
10th	Biosyntech 1994, Laval (Canada), Acquired	Biotherapeutic thermogels for tissue repair	$1.4M	ProQuest Investments, Pappas Capital & 3 others	37/100